CHLA Clinical Research Studies

Having volunteers participate in research studies and clinical trials is critical to our research efforts. Thousands of children and families are involved in our patient-centered studies every year. Many of the treatments used today are based on the results of past research studies and clinical trials conducted with our patients. Our scientific and clinical experts take the best ideas from the laboratory -- to the patient -- in the form of promising new treatments.

By searching our study directory, you may identify research that could impact the life of your child or of another child you know. Because the number of available research studies and clinical trials for children nationwide is small, every participant makes a significant contribution.

In addition to enrolling children with certain diseases in order to study treatments and prevention of those diseases, we also need to study healthy children. Ask your child’s doctor about volunteer study options that may be suitable for your child.

Please contact the study staff listed in your search results for more information.

Search by Keyword:    

Back to the full listing

Study Details - ID: CHLA-20-00118
Health/Science/Disease Category:
Infant Development
Purpose of Research:
Our goal is early identification of deviation from healthy brain development to allow targeted early intervention and improve developmental outcomes.
Short Name:
Smith_Longitudinal EEG and Sensors Study
Full Title of Study:
Emergence of arm reaching behavior and lateralization of motor control in infancy
Phase/Type of Study:
Inclusion Criteria, typical infants: Infants with typical development will be from singleton, full term births. Inclusion Criteria, at risk infants: Infants will be included if they qualify for high risk infant follow up services in California
Time Commitment/Requirements:
Infants will be tested monthly with EEG and motion sensors during the development of arm reaching skills with a follow up phone call or email to assess developmental outcomes occurring when the infant is 24 months of age.
Primary Investigator:
Beth Smith, PT, DPT, PhD
Coordinator Contact Name:
Dana Fine
Phone Number:
Clinical Trials .Gov Identifier: